The management of NAC Kazatomprom JSC (hereinafter – Kazatomprom, the Company) visited the RSE Institute of Nuclear Physics (hereinafter – the Institute of Nuclear Physics, INP) in Almaty. During the visit, Kazatomprom representatives got acquainted with the key aspects of the scientific and production activities of the INP.
The Institute of Nuclear Physics is a unique scientific research organisation in Kazakhstan performing R&D in the field of civil nuclear energy with a full cycle of scientific research and development work, i.e. fundamental, applied research, technology development and production. The only stationary research nuclear BWR-K reactor in Kazakhstan operates at INP, where fundamental research, in-reactor materials science tests, and neutron activation analysis are carried out, and medical radioisotopes and gamma sources for industrial use are produced.
The visit included an exhibition of "hot chambers" equipped with remote-controlled manipulators that allow working with radioactive materials in a safe environment. Another exhibit was the production of radiopharmaceuticals for the diagnosis and therapy of cancer.
In addition, the delegation visited the INP Centre for Integrated Environmental Research, which is one of the leading centres in the field of radioecological monitoring. Exhibits here consisted of equipment and methods for analysing composition of radionuclides and rare earth elements.
Representatives of Kazatomprom and the Institute of Nuclear Physics discussed the prospects for joint research projects covering both the civil nuclear industry and rare and rare earth metals. The parties expressed interest in implementing joint initiatives aimed at developing innovative technologies incentivising innovation.
"We see great opportunities for further collaboration with the Institute of Nuclear Physics. Joint research and development can significantly strengthen our position and promote the introduction of advanced technologies in the civil nuclear industry. This partnership will also create a platform for knowledge exchange, which will contribute both to the development of our company and to strengthening the scientific potential of the country," said Meirzhan Yussupov, CEO of Kazatomprom.
Sayabek Sakhiyev, Director General of the Institute of Nuclear Physics, noted that the INP actively develops and implements civil nuclear industry technology. The Institute produces about 75% of domestic radiopharmaceuticals and supplies them to the country’s medical institutions. Since June of this year, exports of molybdenum-99/technetium-99 generators to the Kyrgyz Republic have begun under an agreement with the IAEA. In addition, the Institute produces and exports isotope cobalt-57 for industrial use to Russia, Germany, USA and France, with plans to expand deliveries to Turkey.
Kazatomprom continues to actively develop partnerships with leading research institutes, striving to enhance its capabilities in the field of nuclear technology and progress in scientific research, which confirms the Company's commitment to innovation and sustainable development.
For more information, please contact:
Public Relations and Media Inquiries
Askar Atagulin, Director, Public Relations
Tel: +7 7172 45 80 63
Email: pr@kazatomprom.kz
Investor Relations Inquiries
Botagoz Muldagaliyeva, Director, Investor Relations
Tel: +7 7172 45 81 80 / 69
Email: ir@kazatomprom.kz
About Kazatomprom
Kazatomprom is the world's largest producer of uranium, with the Company’s attributable production representing approximately 20% of global primary uranium production in 2023. The Group benefits from the largest reserve base in the industry and operates, through its subsidiaries, JVs and Associates, 26 deposits grouped into 14 mining assets. All of the Company’s mining operations are located in Kazakhstan and extract uranium using ISR technology with a focus on maintaining industry-leading health, safety and environment standards.
Kazatomprom securities are listed on the London Stock Exchange, Astana International Exchange, and Kazakhstan Stock Exchange. As the national atomic company in the Republic of Kazakhstan, the Group's primary customers are operators of nuclear generation capacity, and the principal export markets for the Group's products are China, South and Eastern Asia, Europe and North America. The Group sells uranium and uranium products under long-term contracts, short-term contracts, as well as in the spot market, directly from its headquarters in Astana, Kazakhstan, and through its Switzerland-based trading subsidiary, Trade House KazakAtom AG (THK).
For more information, please see the Company website at www.kazatomprom.kz.
Forward-looking statements
All statements other than statements of historical fact included in this communication or document are forward-looking statements. Forward-looking statements give the Company’s current expectations and projections relating to its financial condition, results of operations, plans, objectives, future performance and business. These statements may include, without limitation, any statements preceded by, followed by or including words such as “target,” “believe,” “expect,” “aim,” “intend,” “may,” “anticipate,” “estimate,” “plan,” “project,” “will,” “can have,” “likely,” “should,” “would,” “could” and other words and terms of similar meaning or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company’s control that could cause the Company’s actual results, performance or achievements to be materially different from the expected results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company’s present and future business strategies and the environment in which it will operate in the future.
THE INFORMATION WITH RESPECT TO ANY PROJECTIONS PRESENTED HEREIN IS BASED ON A NUMBER OF ASSUMPTIONS ABOUT FUTURE EVENTS AND IS SUBJECT TO SIGNIFICANT ECONOMIC AND COMPETITIVE UNCERTAINTY AND OTHER CONTINGENCIES, NONE OF WHICH CAN BE PREDICTED WITH ANY CERTAINTY AND SOME OF WHICH ARE BEYOND THE CONTROL OF THE COMPANY. THERE CAN BE NO ASSURANCES THAT THE PROJECTIONS WILL BE REALISED, AND ACTUAL RESULTS MAY BE HIGHER OR LOWER THAN THOSE INDICATED. NONE OF THE COMPANY NOR ITS SHAREHOLDERS, DIRECTORS, OFFICERS, EMPLOYEES, ADVISORS OR AFFILIATES, OR ANY REPRESENTATIVES OR AFFILIATES OF THE FOREGOING, ASSUMES RESPONSIBILITY FOR THE ACCURACY OF THE PROJECTIONS PRESENTED HEREIN.
The information contained in this communication or document, including but not limited to forward-looking statements, applies only as of the date hereof and is not intended to give any assurances as to future results. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to such information, including any financial data or forward-looking statements, and will not publicly release any revisions it may make to the Information that may result from any change in the Company’s expectations, any change in events, conditions or circumstances on which these forward-looking statements are based, or other events or circumstances arising after the date hereof.